Avascular Necrosis News and Research

RSS
Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Zometa improves OS, PFS in newly diagnosed multiple myeloma patients: Phase III study

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft

BCF publishes two new patient publications

BCF publishes two new patient publications

One-step surgery positively impacts patient's quality of life: Study

One-step surgery positively impacts patient's quality of life: Study

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Positive results from new analyses of denosumab Phase 3 trials

Positive results from new analyses of denosumab Phase 3 trials

FDA approves Prolia for postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

ACOEM publishes new medical treatment guidelines for hip and groin disorders

ACOEM publishes new medical treatment guidelines for hip and groin disorders

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

27-year-old sickle cell disease patient undergoes multiple joint replacement surgery

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Potential new treatment for osteonecrosis

Potential new treatment for osteonecrosis

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases